Translational Research in Methamphetamine Addiction Conference

描述(由申请人提供)：甲基苯丙胺成瘾在美国构成了一个严重且日益严重的药物滥用问题。到目前为止，还没有专门研究甲基苯丙胺成瘾的基础和临床神经生物学的全国性会议。拟议的甲基苯丙胺成瘾转化研究大会计划于2010年7月举行，由NIDA支持的两个甲基苯丙胺研究中心共同赞助：南卡罗来纳医科大学的甲基苯丙胺转化研究中心和加州大学洛杉矶分校的甲基苯丙胺转化研究中心。这次会议将对成瘾研究人员具有广泛的吸引力，并将为以甲基苯丙胺滥用和依赖的基础和临床神经生物学为中心的研究互动提供催化剂。会议的议题和组织形式将允许交叉交流对全面探索甲基苯丙胺成瘾至关重要的领域的专业知识，包括药理学、神经生物学、动物模型、临床评估、脑成像和新的治疗方法。在这次会议上，基础和临床研究人员的结合将允许独特的跨学科水平的交流，并鼓励未来出现新的研究、培训和治疗机会。临床前陈述将与临床陈述紧密地并列在一起，从而促进将不同研究方法产生的发现结合在一起的能力，以一致地理解甲基苯丙胺成瘾的临床神经生物学基础。此外，年轻的研究人员将有极好的机会在会议上与来自全国各地的领先的甲基苯丙胺研究人员互动。会议的主题整合将聚焦于研究活动的多个维度，目标是在甲基苯丙胺成瘾、功能障碍和治疗领域提供翻译报道。因此，这次会议将是第一次提供关于甲基苯丙胺成瘾的论坛，明确与美国国立卫生研究院路线图倡议相一致。 公共卫生相关性：拟议的甲基苯丙胺成瘾转化研究会议计划于2010年7月举行，由MUSC成瘾转化研究中心和加州大学洛杉矶分校成瘾转化研究中心共同主办。会议将包括对甲基苯丙胺成瘾的临床前和临床层面的全面探索。会议的主题整合将为成瘾研究人员提供一个独特的论坛，讨论目前在甲基苯丙胺成瘾方面的发现。

DESCRIPTION (provided by applicant): Methamphetamine addiction constitutes a serious and growing drug abuse problem in the United States. To date, there has not been a national conference devoted to the basic and clinical neurobiology of methamphetamine addiction. The proposed Translational Research in Methamphetamine Addiction conference is planned for July of 2010 and is co-sponsored by two NIDA-supported methamphetamine research centers: the Translational Research in Addiction Center at the Medical University of South Carolina and the Center for Translational Research of Addiction at the University of California, Los Angeles. This conference will have broad appeal to addiction researchers and will provide a catalyst for research interactions centered on the basic and clinical neurobiology of methamphetamine abuse and dependence. The topics and organizational format of the meeting will allow cross fertilization of expertise in areas that are critical to a comprehensive exploration of methamphetamine addiction, including pharmacology, neurobiology, animal models, clinical assessment, brain imaging, and novel treatment. The combination of basic and clinical researchers at this conference will allow unique interdisciplinary levels of communication and encourage the future emergence of new research, training, and treatment opportunities. The preclinical presentations will juxtapose closely with the clinical presentations and thereby facilitate the capacity to unite discoveries emerging from different research approaches into a coherent understanding of the clinical neurobiological basis of methamphetamine addiction. Furthermore, young investigators will have excellent opportunities at the conference to interact with leading methamphetamine researchers from around the country. The thematic integration of the conference will focus multiple dimensions of research activity with the goal of providing translational coverage in the field of methamphetamine addiction, dysfunction, and treatments. As such, the conference will be the first of its kind to provide a forum on methamphetamine addiction that is clearly aligned with the NIH Roadmap Initiative. PUBLIC HEALTH RELEVANCE: The proposed Translational Research in Methamphetamine Addiction conference is planned for July of 2010 and is co-sponsored by the MUSC Translational Research in Addiction Center and the UCLA Center for Translational Research of Addiction. The conference will include a comprehensive exploration of methamphetamine addiction at the preclinical and clinical levels. The thematic integration of the conference will offer addiction researchers a unique forum on current findings in methamphetamine addiction.